Skip to main content

and
Your search also matched 6 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial

Include preview-only content
  1. Article

    Open Access

    Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial

    This study evaluated azacitidine as treatment of minimal residual disease (MRD) determined by a sensitive donor chimerism analysis of CD34+ blood cells to pre-empt relapse in patients with CD34+ myelodysplastic s...

    U Platzbecker, M Wermke, J Radke, U Oelschlaegel, F Seltmann, A Kiani, I-M Klut in Leukemia (2012)

  2. Chapter

    Substanzprofile: Zytostatika, Hormone, Zytokine1

    U. Keilholz, H. Knoth, H. Sauer in Kompendium Internistische Onkologie (2006)

  3. Article

    Open Access

    Industry-sponsored economic studies in oncology vs studies sponsored by nonprofit organisations

    The purpose of this analysis of health economic studies in the field of oncology was to investigate among sponsored studies whether any relationship could be established between the type of sponsorship and (1)...

    M Hartmann, H Knoth, D Schulz, S Knoth in British Journal of Cancer (2003)